This essential volume explores a variety of tools and prools of structure-based (homology modeling, molecular docking, molecular dynamics, protein-protein interaction network) and ligand-based (pharmacophore mapping, quantitative structure-activity relationships or QSARs) drug design for ranking and prioritization of candidate molecules in search of effective treatment strategy against coronaviruses. Beginning with an introductory section that discusses coronavirus interactions with humanity and COVID-19 in particular, the book then continues with sections on tools and methodologies, literature reports and case studies, as well as online tools and databases that can be used for computational anti-coronavirus drug research. Written for the
Methods in Pharmacology and Toxicology
series, chapters include the kind of practical detail and implementation advice that ensures high quality results in the lab.
Comprehensive and timely,
In Silico Modeling ofDrugs Against Coronaviruses: Computational Tools and Prools
is an ideal reference for researchers working on the development of novel anti-coronavirus drugs for SARS-CoV-2 and for coronaviruses that will likely appear in the future.